Credit Card Icon
Online bill pay
Calendar Icon
Book Now
Filed Paper Icon
patient portal
Doctor Icon
For Physicians
Phone Icon
(763) 416-7600

Low-Tension Glaucoma for Eye Health

Posted by: Northwest Eye in low tension glaucoma on May 23, 2026

Normal pressure does not rule out glaucoma

Low-tension glaucoma can damage the optic nerve even when eye-pressure readings stay in the usual 10 to 21 mmHg range. The condition is not the same as having low eye pressure without glaucoma. It involves optic-nerve damage. Normal-tension glaucoma can share open angles, optic-nerve cupping, and visual-field loss with primary open-angle glaucoma, but the optic nerve appears more vulnerable at relatively lower pressures.

The usual eye-pressure range is described as 10 to 21 mmHg, and this form of glaucoma can occur at 21 mmHg or below. The drainage angles may remain open while the optic nerve becomes damaged, the nerve-fiber layer thins, and visual-field changes develop. A normal eye-pressure reading does not by itself rule out glaucoma.

A single reading also gives only one moment in time. In the United States, 15% to 25% of people with signs of open-angle glaucoma have had a single eye-pressure measurement within the normal range. That figure describes one measurement, not a diagnosis of low-tension glaucoma.

Treatment decisions depend on the whole pattern: your optic nerve, visual field, pressure readings, corneal thickness, and change over time. In one study of people with this condition, a 30% reduction in eye pressure lowered the reported long-term risk of worsening from 35% to 12%. That study result does not make a 30% reduction your personal target. Your next useful step is to understand how the examination confirms whether the pattern is present.

Why the optic nerve can be vulnerable

The optic nerve can be vulnerable to pressure that falls within the usual measured range, but no single cause fully explains this condition. Researchers propose several possible mechanisms, including greater sensitivity to normal pressure, changes in blood-vessel regulation, an unusual pressure balance around the optic nerve, and altered fluid dynamics around the nerve.
Low-tension glaucoma has been associated with several factors:

  • Migraine and vasospastic disorders, which involve abnormal narrowing or widening of blood vessels.
  • Low blood pressure, especially at night.
  • Vascular or endothelial disease, which can affect how blood vessels respond.
  • Obstructive sleep apnea and other conditions that may reduce blood flow to the optic nerve.
  • Optic-disc hemorrhages, which are small bleeding areas at the optic nerve.

These associations do not prove that any one factor caused your glaucoma. It also remains unclear whether finding or treating these conditions changes the disease course in every person.

Studies have associated excessive nighttime blood-pressure dipping with greater odds of visual-field progression. The reported estimate was 3.32 for systolic dipping, with a reported 95% range of 1.84 to 6.00. For diastolic dipping, the reported estimate was 2.09, with a reported 95% range of 1.20 to 3.64. These studies did not prove that nighttime blood-pressure changes caused progression.

A nighttime reduction in mean arterial pressure of more than 10 mmHg below daytime levels may predict progression, but this does not prove that it causes progression. That distinction matters: do not stop or change blood-pressure treatment based on glaucoma information alone.

Pressure readings from different times can be interpreted alongside medication use and blood-pressure patterns. This comparison does not diagnose a cause, but it can show why one office value may not represent the full pattern.

Vascular dysregulation means that a tissue cannot keep its blood supply steady when perfusion pressure changes. Vascular dysregulation may help explain why a normal office pressure does not describe every factor affecting the optic nerve, but vascular dysregulation does not identify a cause in an individual patient. A history of migraine, vasospasm, vascular disease, or nighttime low blood pressure is information to share during evaluation, not a self-diagnosis. Clinicians may review those details when considering why damage progresses despite apparently normal pressure.

Infographic on nighttime blood-pressure dipping and visual-field progression. It shows a 3.32 systolic estimate with a 95% range of 1.84-6, a 2.09 diastolic estimate with a 95% range of 1.2-3.64, and a nighttime mean-pressure reduction greater than 10 mmHg below daytime levels.
The reported estimates describe associations, not a proven cause of progression.

Early disease may not feel different

Early low-tension glaucoma often causes no noticeable symptoms. An examination may detect optic-nerve changes before you notice a problem.

When visual-field loss develops, it may affect peripheral or tunnel vision. With this form of glaucoma, field defects also tend to be closer to the center of vision and may be greater than the optic-nerve appearance alone would suggest.
Possible findings include:

  • Missing or dim areas in side vision.
  • Field changes closer to the center of vision.
  • A difference between the two eyes.
  • An optic-disc hemorrhage, which is uncommon but can be a worrisome sign of poorly controlled glaucoma.

An optic-disc hemorrhage may be associated with visual-field progression over the next 17 to 20 months. That timeframe describes a reported association, not a prediction of what will happen to you. New, asymmetric, or concerning field changes deserve prompt qualified assessment rather than watchful waiting at home.

What the eye examination checks

A low-tension glaucoma evaluation looks for optic-nerve damage and visual-field loss while checking for other explanations. An eye-care professional should perform a comprehensive eye examination, including gonioscopy, when evaluating possible disease. Gonioscopy examines the drainage angle inside the eye.

The evaluation may include:

  • Tonometry, which measures eye pressure.
  • Gonioscopy, which checks whether the drainage angle is open.
  • A dilated examination of the optic nerve.
  • Optical coherence tomography, or OCT, to image the optic nerve and retinal nerve-fiber layer.
  • Visual-field testing to look for blind spots or areas of reduced sensitivity.
  • Corneal-thickness measurement, because corneal thickness can affect how pressure readings are interpreted.

The clinician may compare the appearance of your optic nerve with your visual-field results. A normal pressure reading does not outweigh clear evidence of progressive optic-nerve injury. The pattern across several tests is more useful than any isolated number.

If the optic nerve looks atypical, a clinician may recommend brain and optic-nerve imaging to look for other causes of damage. Asymmetric disease or concerning field defects may warrant additional neurologic or other specialist workup. Those steps do not mean that another condition has been found; they help determine whether the findings fit glaucoma.

Each part of the evaluation answers a different question. Tonometry shows the pressure at the time of measurement, but pressure can vary during the day. Gonioscopy shows whether the drainage angle is open. A dilated optic-nerve examination looks for cupping or other visible changes. OCT can show thinning in the retinal nerve-fiber layer. Visual-field testing checks whether the optic nerve’s damage affects side or central vision. Corneal-thickness measurement helps the clinician interpret the pressure reading, because thin corneas can affect that interpretation and can increase glaucoma risk.

The results are considered together rather than ranked by one number. A normal pressure with an abnormal field or optic-nerve finding can still require further evaluation. A pressure reading alone cannot establish that the optic nerve is damaged. Repeat fields, photographs, or nerve-fiber images provide a comparison for later visits. If the pattern is asymmetric or does not fit glaucoma, additional imaging or specialist workup may be appropriate. Visual-field testing measures vision function, while OCT imaging measures the retinal nerve-fiber layer, so the two tests provide different kinds of follow-up information.

Why one pressure reading is not enough

One eye-pressure reading may miss pressure changes during the day. A clinician may repeat measurements or use a diurnal pressure curve, which checks pressure at different times. This can show whether pressure rises outside the clinic even when a single office reading looks normal.

Your clinician can also establish baseline measurements and compare them later. Useful comparisons may include:

  • Optic-nerve photographs.
  • Visual-field test results.
  • OCT or other nerve-fiber imaging.
  • Eye-pressure readings from different visits or times of day.

A change is more meaningful when it appears consistently across follow-up tests. A stable visual field and stable nerve-fiber measurements may support continued monitoring, while a repeatable change may prompt treatment or additional evaluation.

One study modeled a 30% reduction in eye pressure from baseline over a 10-year horizon. That was an economic and disease-progression model, not an individual treatment plan. A model cannot tell you which pressure target, medicine, laser treatment, or surgery is appropriate for your eyes.

How treatment and monitoring are chosen

Treatment for low-tension glaucoma usually focuses on lowering eye pressure, even when the starting pressure is in the normal range. The aim is to reduce stress on the optic nerve while your visual fields and nerve-fiber measurements are followed over time.

Management may include:

  • Pressure-lowering eye drops.
  • Laser treatment.
  • Surgery to lower eye pressure.
  • Repeat visual-field testing and nerve-fiber imaging.
  • Review of blood-pressure patterns or sleep-related conditions when progression continues despite eye treatment.

Eye-pressure-lowering medicines are often tried first. Prostaglandin analogue drops can lower eye pressure and have been shown to control it throughout a 24-hour day. Filtering surgery may be considered when pressure remains inadequately controlled while visual fields worsen and optic-nerve injury progresses.

The benefit of lowering pressure is not identical for everyone. In the cited study, nearly 50% of untreated patients did not experience progression over 5 to 7 years. That finding does not mean treatment is unnecessary; it shows why your clinician weighs documented progression, the location of field loss, optic-nerve findings, and other risks before choosing a plan.

If the condition worsens despite treatment, your clinicians may consider a systemic evaluation. That evaluation may include a sleep study or 24-hour blood-pressure monitoring. Do not arrange or interpret those tests as a substitute for the eye examination.

Infographic comparing three low-tension glaucoma treatment options: eye drops, laser, and surgery. It shows their roles, when they are considered, and the need to follow visual fields and nerve-fiber measurements.
Treatment choice depends on documented progression and follow-up findings.

What pressure targets can mean

A pressure target is chosen from your disease pattern, not from the word normal alone. Treatment often follows the primary open-angle glaucoma approach but aims for lower pressure because the optic nerve has shown damage at a pressure that may look typical on a chart.

One cited guideline is a reduction of at least 20%, although the target must be individualized. For patients with documented progression or a threat to fixation, the cited study found that a 30% reduction could prevent visual-field progression in most patients.

These figures describe study groups and treatment contexts. They do not mean that every person should lower pressure by exactly 20% or 30%, and they do not identify a safe pressure for your eyes. Some eyes need a larger reduction, while others may be monitored before treatment is changed.

Your clinician may use several questions when setting a target:

  • Has your visual field changed on repeat testing?
  • Is the change near the center of vision?
  • Does the optic nerve or nerve-fiber layer show progression?
  • Are pressure readings higher at another time of day?
  • Do other findings suggest a different cause of optic-nerve damage?

A target is useful only when it is paired with follow-up measurements. The plan may change if your field, nerve imaging, or pressure pattern changes.

Pressure examples of 12 mmHg, 10 mmHg, and 8 mmHg are not personal prescriptions or proof that lower pressure is always better. A clinician may use repeatable visual-field or nerve-fiber changes, baseline pressure, and the eye’s apparent vulnerability to decide whether a pressure target is adequate. Ask what measurement will show that a pressure target is working and when a clinician will reassess the pressure target. A pressure target without planned visual-field, nerve-fiber, and pressure follow-up cannot show whether the disease pattern is stable.

Infographic showing pressure reduction targets in low-tension glaucoma: a cited guideline recommends at least 20%, while a study examined a 30% reduction.
Pressure targets are based on disease pattern, not the word normal alone.

Review medicines and blood pressure safely

Medicine review matters because some treatments can affect nighttime blood pressure. Beta-blocker eye drops may lower nighttime blood pressure and may contribute to progression in some people with low-tension glaucoma. That possibility does not mean you should stop a prescribed drop.

Bring a complete list of your medicines, including eye drops, blood-pressure medicines, sleep medicines, and nonprescription products. Include the dose and the time you use each medicine if you know them. Tell your eye-care professional about very low blood-pressure readings, dizziness, migraine, sleep apnea, or symptoms that occur at night.

Ask your eye-care professional whether reviewing nighttime blood-pressure treatment with your primary-care clinician is appropriate. Do not change blood-pressure medicine on your own. A primary-care clinician may need to balance blood-pressure control with the possible effect of nighttime pressure on optic-nerve blood flow.

What treatment can and cannot do

Treatment may slow or stop further glaucoma progression, but it cannot restore optic-nerve fibers that have already been damaged. Vision lost from low-tension glaucoma-related optic-nerve damage cannot be recovered because damaged nerve fibers do not regenerate.

There is no cure for glaucoma, but treatment may help prevent progression and preserve the vision you still have. Your eye specialist must assess the outlook for your individual case.

This is why monitoring remains part of treatment even when you feel no different. A lack of symptoms does not show that the optic nerve is stable, and a single normal pressure reading does not show that treatment is working. Follow-up visual fields, nerve imaging, optic-nerve photographs, and pressure measurements give your care team ways to look for change.

What low-tension glaucoma care may cost

Low-tension glaucoma treatment costs vary with the treatment plan, the number of tests, the medicines used, insurance coverage, and whether a procedure is needed. Published U.S. estimates give useful planning ranges, but they are not a quote for your care.

Here is how the main cost categories differ:

  • Comprehensive examination: Without insurance, a comprehensive eye exam that includes glaucoma screening may exceed $200. The amount depends on the examination and the office.
  • Prescription eye drops: One U.S. estimate places prescription glaucoma drops at $240 to $2,500 per year. The range covers medication costs, not every examination or follow-up charge.
  • Procedures: A U.S. source gives a range of $1,000 to $6,300 for surgical procedures. The source does not establish what your insurer or a particular office will charge.
  • Out-of-pocket responsibility: Your amount depends on insurance coverage. Ask the eye doctor’s office what you would pay after coverage for a planned procedure.

A separate study modeled the cost-effectiveness of treating all normal-tension glaucoma with a 30% eye-pressure reduction. It reported an incremental cost-effectiveness ratio of US$34,225 per quality-adjusted life year over the study model’s 10-year horizon. That is a population-level economic result, not a bill, price, or personal recommendation. Ask for the expected examination, testing, medicine, and procedure costs that apply to your plan.

Retailers and community clinics often offer more affordable basic eye exams. Prescription-drug estimates also vary with the medicine and coverage, so an annual range is not a fixed bill. The economic model’s cost-effectiveness ratio answers a population-level question about value over time. It does not predict the amount due for an examination, medicine, procedure, or follow-up visit. Ask which services are included in any estimate and which amount remains your responsibility after insurance.

Insurance and published estimates answer different questions. A published range shows the broad amount associated with a category, while an insurer’s estimate determines how a deductible, copayment, coinsurance, or coverage rule affects your share. Ask whether a quoted amount includes the examination, visual-field testing, OCT or other imaging, medicines, and follow-up. Ask the eye-care office and insurer what amount would remain your responsibility for the specific examination, test, medicine, or procedure. Keep each estimate tied to the service being discussed, because an annual medication range does not predict a procedure bill.

Infographic comparing three U.S. low-tension glaucoma cost categories. It shows an examination may exceed $200, eye drops may cost $240 to $2,500, and procedures may range from $1,000 to $6,300.
Insurance coverage and the treatment plan determine the amount you pay.

Start with a comprehensive eye examination

A comprehensive eye examination is the practical starting point when you are concerned about low-tension glaucoma or have been asked to follow up on a pressure reading. The visit can establish pressure, optic-nerve, nerve-fiber, and visual-field information for comparison later.

Before the appointment, prepare these details:

  • Any new, missing, or distorted areas in your vision.
  • Whether the change affects one eye or both eyes.
  • The date and result of any earlier eye-pressure or visual-field test.
  • Every eye drop, blood-pressure medicine, and other medicine you use.
  • A history of migraine, very low blood pressure, sleep apnea, or nighttime symptoms.
  • Questions about the number of tests, follow-up timing, treatment choices, and expected costs.

During the visit, ask how each test relates to the concern. You can ask whether your drainage angles are open, whether the optic nerve or nerve-fiber layer shows damage, whether the visual field matches the nerve findings, and whether pressure needs to be measured at more than one time of day.

Bring your glasses, medication list, and any prior eye records you can obtain. These details help the care team compare findings instead of treating one pressure number as the entire picture. A prior test result is most useful when it includes the test date, because clinicians compare findings over time rather than relying on an undated result.

Know which findings need prompt qualified help

If you are unsure how urgent the change is, contact a qualified eye-care professional promptly. A clinician may need to repeat the visual field, examine the optic nerve, or investigate another cause instead of assuming that a normal pressure reading explains the finding.

Contact your eye-care team promptly if you notice:

  • A new missing or dim area in your vision.
  • A change that seems stronger in one eye.
  • A field defect near the center of vision.
  • A new concern after a visual-field test or optic-nerve examination.
  • A clinician telling you that the optic nerve looks atypical or that the findings do not match the usual glaucoma pattern.

If the optic nerve looks atypical, brain and optic-nerve imaging may be recommended to look for other causes of damage. Do not change blood-pressure medicine or glaucoma treatment on your own while waiting for that evaluation. Sudden or rapidly worsening vision changes require immediate qualified eye care. Do not change prescribed medicines while waiting.

Book the next eye-care discussion

Low-tension glaucoma cannot be judged from eye pressure alone. Bring your symptoms, medicine list, prior test results, and cost questions to the appointment so you can review the pressure pattern, optic nerve, visual field, monitoring schedule, and treatment choices together. A qualified eye-care professional must decide whether the findings fit glaucoma and which plan suits your eyes.

Northwest Eye in Minnetonka can be the place to discuss possible low-tension glaucoma, follow-up testing, monitoring, treatment options, and expected costs.

Questions to ask about low-tension glaucoma

What might low-tension glaucoma care cost in the United States?

Costs vary with the examination, testing, medicines, procedures, insurance, and your out-of-pocket responsibility. A comprehensive uninsured exam may exceed $200, prescription drops may cost $240 to $2,500 per year, and one source lists procedures at $1,000 to $6,300. Ask the eye-care office what your plan would cover and what you would pay.

Will I need surgery for low-tension glaucoma?

Surgery is not automatically needed. Pressure-lowering medicines are often tried first, while laser treatment or surgery may be considered if pressure remains inadequately controlled and visual fields or optic-nerve findings continue to worsen. Your clinician bases that decision on repeat testing, the location of damage, pressure patterns, and your response to treatment.

Should I change my blood-pressure medicine if I have low-tension glaucoma?

Do not stop or change blood-pressure medicine on your own. Nighttime low blood pressure may be relevant for some people, so tell your eye-care professional about dizziness, low readings, nighttime medicines, or sleep-related concerns. If appropriate, your eye-care professional and primary-care clinician can review the treatment together and balance blood-pressure control with optic-nerve concerns.

What happens if low-tension glaucoma worsens despite treatment?

Continued worsening may lead your clinicians to confirm the pressure pattern, review treatment, and look for other contributors or causes of optic-nerve damage. A systemic evaluation may include a sleep study or 24-hour blood-pressure monitoring. Atypical optic-nerve findings or asymmetric field defects may also prompt brain or optic-nerve imaging or other specialist evaluation.


locations

Serving Our Community

With six locations throughout the Twin Cities metro area, Northwest Eye is among the largest eye care providers in the Midwest. Be Eye Wise and schedule a general eye exam or a specific service consultation today. We have optical  at the following offices:  Golden Valley, Minnetonka, Maple Grove, St. Anthony, and Wayzata, MN.

8501 Golden Valley Rd.,
Suite 100 & 200
Golden Valley, MN 55427
Additional Golden Valley Information
12501 Whitewater Drive, Suite 110
Minnetonka, MN 55343
Additional Minnetonka Clinic (Crosstown) Information
12000 Elm Creek Blvd N., Suite 100
Maple Grove, MN 55369
Additional Maple Grove Information
2601 39th Ave NE., Suite 1
St. Anthony, MN 55421
Additional St. Anthony Information
1903 E. Wayzata Blvd., Suite 110
Wayzata, MN 55391

Additional Wayzata Information
7125 Tamarack Rd, Suite 150,
Woodbury, MN 55125
Additional Woodbury Information
11091 Ulysses St NE., Suite 400
Blaine, MN 55434
Additional Blaine Surgery Center Information
9801 Dupont Ave S., Suite 100
Bloomington, MN 55431
Additional Bloomington Surgery Center Information
12501 Whitewater Drive
Suite 320
Minnetonka, MN 55343
Additional Crosstown Surgery Center Information
10709 Wayzata Blvd., Suites 100 & 120
Minnetonka, MN 55305
Additional Minnetonka Surgery Center Information